טוען...
Impact of Medicaid Restrictions on Availability of Buprenorphine in Addiction Treatment Programs
Objectives. To examine how utilization restrictions on state Medicaid benefits for buprenorphine are related to addiction treatment programs’ decision to offer the drug. Methods. We used data from 2 waves of the National Drug Abuse Treatment System Survey conducted in 2014 and 2017 in the United Sta...
שמור ב:
| הוצא לאור ב: | Am J Public Health |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Public Health Association
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6366513/ https://ncbi.nlm.nih.gov/pubmed/30676789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2105/AJPH.2018.304856 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|